品牌 |
Leading Biology |
貨號(hào) |
LM20213 |
產(chǎn)品分類 |
單克隆抗體 |
研究領(lǐng)域 |
|
產(chǎn)品概述 |
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
|
形式 |
PKC Potentiated Inhibitor Protein-17 (CPI-17) is a 17 kDa protein (1). Expressed in smooth muscles and neuronal cells, CPI-17 is a myosin phosphatase inhibitor protein. Phosphorylation of CPI-17 at Thr38 enhances its inhibitory effect by 100 fold (2). Once phosphorylated, CPI-17 inhibits PP1c and MLCP holoenzyme activity (3).
|
濃度 |
A synthetic peptide corresponding to residues in the N-term of human CPI-17 aplha was used as immunogen. This antibody may also detect isoform CPI-17 beta. |
純度 |
Rabbit |
試劑準(zhǔn)備 |
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
|
復(fù)溶 |
1. Eto M, Ohmori T, Suzuki M, Furuya K & Morita F (1995). J Biochem 118, 1104-1107<br>2. Eto M, Senba S, Morita F & Yazawa M (1997). FEBS Lett 410, 356-360<br>3. Senba S, Eto M & Yazawa M (1999). J Biochem 125, 354-362<br>
|
儲(chǔ)存條件 |
Human, Rat
|
儲(chǔ)存溶液 |
Protein phosphatase 1 regulatory subunit 14A, 17 kDa PKC-potentiated inhibitory protein of PP1, Protein kinase C-potentiated inhibitor protein of 17 kDa, CPI-17, PPP1R14A, CPI17, PPP1INL
|
應(yīng)用 |
WB~~1:1000~5000
IHC~~1:250~500
|
產(chǎn)品描述 |
Function
Inhibitor of PPP1CA. Has over 1000-fold higher inhibitory activity when phosphorylated, creating a molecular switch for regulating the phosphorylation status of PPP1CA substrates and smooth muscle contraction.
Cellular_Location
Cytoplasm.
Tissue_Location
Isoform 1 is detected in aorta and testis. Isoform 2 is detected in aorta.
|
數(shù)量 |
|